Prenatal screening analysis reveals cell-free DNA fragmentation patterns detect adverse pregnancy outcomes in immune-mediated diseases, indicating early noninvasive diagnostic utility.
cfDNA fragmentomics of routine prenatal screening data identifies adverse pregnancy outcomes in immune-mediated disease (Stanley et al. , this issue).
No takes yet. Share an insight, caveat, or question.
Sadeghi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: